TABLE 3.
# of Vaccinations
|
|||
---|---|---|---|
Stimulus | 0 | 2 | 4 |
pg/ml IFN-γ | |||
T2/ESO-1 (N) | 380 | 2896 | 2723 |
T2/ESO-1 (9V) | 309 | 2994 | 2554 |
T2/gp 100:180-188 | 234 | 45 | 22 |
Unpulsed T2 | 282 | 57 | 20 |
624mel (A2+, ESO-1+) | 105 | 21 | 10 |
1363mel (A2+, ESO-1+) | 83 | 62 | 20 |
624.28mel (A2−, ESO-1+) | 41 | 15 | 1 |
526mel (A2+, ESO-1−) | 29 | 5 | 0 |
None | 124 | 27 | 15 |
ESO-1(N), native NY-ESO-1:157-165 peptide; ESO-1(9V), modified peptide NY-ESO-1:157-165(9V); gp100:180-188, irrelevant peptide.